These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 12115382)

  • 61. Ovarian cancer arising in endometrioid cysts: ultrasound findings.
    Testa AC; Timmerman D; Van Holsbeke C; Zannoni GF; Fransis S; Moerman P; Vellone V; Mascilini F; Licameli A; Ludovisi M; Di Legge A; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):99-106. PubMed ID: 21351179
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
    Drapkin R; von Horsten HH; Lin Y; Mok SC; Crum CP; Welch WR; Hecht JL
    Cancer Res; 2005 Mar; 65(6):2162-9. PubMed ID: 15781627
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
    Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
    Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Precursors of endometrial clear cell carcinoma.
    Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [TBL] [Abstract][Full Text] [Related]  

  • 65. p53, c-erbB-2 and p21ras expression in tumor effusion cells of patients with histopathologically different ovarian neoplasms.
    Harłozińska A; Bar JK; Sobańska E; Goluda M
    Anticancer Res; 1997; 17(5A):3545-52. PubMed ID: 9413200
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy.
    Skirnisdóttir I; Seidal T; Gerdin E; Sorbe B
    Int J Gynecol Cancer; 2002; 12(3):265-76. PubMed ID: 12060448
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
    Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
    Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
    Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
    Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe.
    Kalir T; Eisberg A; Dottino P; Cohen C
    Gynecol Oncol; 1999 Feb; 72(2):208-14. PubMed ID: 10021303
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy.
    Nishio N; Kido A; Kataoka M; Kuwahara R; Nakao K; Kurata Y; Matsumura N; Mandai M; Togashi K
    Eur J Radiol; 2018 Aug; 105():175-181. PubMed ID: 30017276
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
    Horiuchi A; Osada R; Nakayama K; Toki T; Nikaido T; Fujii S
    Gynecol Oncol; 1998 Aug; 70(2):295-9. PubMed ID: 9740709
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
    Kato M; Yamamoto S; Takano M; Matsubara O; Furuya K
    Int J Gynecol Pathol; 2012 May; 31(3):254-63. PubMed ID: 22498943
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epithelial abnormalities in cystic ovarian endometriosis.
    Prefumo F; Todeschini F; Fulcheri E; Venturini PL
    Gynecol Oncol; 2002 Feb; 84(2):280-4. PubMed ID: 11812087
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
    Xiao W; Awadallah A; Xin W
    Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
    McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
    Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma.
    Chivukula M; Dabbs DJ; O'Connor S; Bhargava R
    Int J Gynecol Pathol; 2009 Nov; 28(6):570-8. PubMed ID: 19851209
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Significance of apoptosis related proteins on malignant transformation of ovarian tumors: A comparison between Bcl-2/Bax ratio and p53 immunoreactivity.
    Zeren T; Inan S; Vatansever HS; Sayhan S
    Acta Histochem; 2014 Oct; 116(8):1251-8. PubMed ID: 25108507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.